Target intelligence / Profile preview

Natural killer cell granule protein 7 (NKG7)

Target
NKG7
Molecular classification
Other (lytic granule-associated membrane protein of cytotoxic lymphocytes)
01

Overview

Natural killer cell granule protein 7 (NKG7) is a membrane protein found primarily in the cytolytic granules of NK cells and cytotoxic T lymphocytes. It plays a key role in regulating granule exocytosis, which is essential for the destruction of infected or malignant cells. NKG7 is upregulated during immune activation and is involved in both the direct cytotoxic function of NK and CD8+ T cells and the activation of CD4+ T cells. It serves as a robust marker of cytotoxic immune cells across tissues and disease settings, including cancer and infection. Disruption of NKG7 impairs immune synapse efficiency, resulting in deficient cytolysis and prolonged cell-to-cell contact that can lead to excessive cytokine release and inflammation. No currently approved drugs directly target NKG7, but its role makes it a potential therapeutic or biomarker candidate for immuno-oncology and infection-related research.

Other names
GIG1GMP-17p15-TIA-1G-CSF-induced gene 1 proteingranule membrane protein 17granule membrane protein of 17 kDanatural killer cell protein 7natural killer cell group 7 sequence
02

Mechanism of action

Enhancement of immune cell cytotoxicity through granule exocytosis (drugs would act by modulating exocytosis or immune synapse efficiency, but no direct drug interaction known)

03

Biological functions

Immune responseRegulation of cytotoxic granule exocytosisCytolytic activity in natural killer (NK) cells and CD8+ T cellsActivation of CD4+ T cells after infectionRegulation of inflammation
04

Disease associations

CancerInfection (including malaria, visceral leishmaniasis)Inflammation
05

Safety considerations

Potential for excessive inflammation due to hypersecretion of cytokines if dysregulatedRisk of impaired cytotoxic immune responses if inhibited
06

Biomarkers

Marker of cytotoxic lymphocyte activity (marker for functional CD8+ T cells and NK cells in tumors and infection)

Beyond the preview

Go deeper on Natural killer cell granule protein 7 (NKG7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell granule protein 7 (NKG7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call